27
Sep
Sep
The US Food and Drug Administration (FDA) has approved Cobenfy, a up-to-date breakthrough drug for schizophrenia that promises to revolutionize treatment with a novel mechanism, the first of its kind in decades. Schizophrenia is a solemn and disabling mental illness that affects the way a person thinks, feels and behaves. Approximately 1% of Americans suffer […]